Shahzada Rashid

Dr. Shahzada Rashid

Sheri kashmir institute of agricultural science & technology
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SASheikh B Ahmad
Sheikh B Ahmad
AAAarif Ali
Aarif Ali
MBMidhat Bilal
Midhat Bilal
SRShahzada Rashid
Shahzada Rashid
AWAmir Bashir Wani
Amir Bashir Wani
MRMuneeb U Rehman
Muneeb U Rehman

14 February 2019 in Current Neuropharmacology
Verified
Journal Article
Closed access
PDF file
MRMuneeb U. Rehman
Muneeb U. Rehman
AWAdil Farooq Wali
Adil Farooq Wali
AAAnas Ahmad
Anas Ahmad
SSSheeba Shakeel
Sheeba Shakeel
SRSaiema Rasool
Saiema Rasool
RKRehan Khan
Rehan Khan
Nature has bestowed mankind with surplus resources (natural products) on land and water. Natural products have a significant role in the prevention of disease and boosting of health in humans and animals. These natural products have been experimentally documented to possess various biological properties such as antioxidant, anti-inflammatory and anti-apoptotic activities. In vitro and in vivo studies have further established the usefulness of natural products in various preclinical models of neurodegenerative disorders. Natural products include phytoconstituents, like polyphenolic antioxidants, found in herbs, fruits, nuts, vegetables and also in marine and freshwater flora. These phytoconstituents may potentially suppress neurodegeneration and improve memory as well as cognitive functions of the brain. Also, they are known to play a pivotal role in the prevention and cure of different neurodegenerative diseases, such as Alzheimer’s disease, epilepsy, Parkinson’s disease and other neuronal disorders. The large-scale neuro-pharmacological activities of natural products have been documented due to the result of either the inhibition of inflammatory processes, or the up-regulation of various cell survival proteins or a combination of both. Due to the scarcity of human studies on neuroprotective effects of natural products, this review focuses on the various established activities of natural products in in vitro and in vivo preclinical models, and their potential neuro-therapeutic applications using the available knowledge in the literature.

25 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
AAAzher Arafah
Azher Arafah
SKsaima khatoon
saima khatoon
IRIyman Rasool
Iyman Rasool
Andleeb KhanAndleeb Khan
Andleeb Khan
MRMashoque Ahmad Rather
Mashoque Ahmad Rather
MRMuneeb U Rehman
Muneeb U Rehman
This decade has seen the beginning of ground-breaking conceptual shifts in the research of Alzheimer’s disease (AD), which acknowledges risk elements and the evolving wide spectrum of complicated underlying pathophysiology among the range of diverse neurodegenerative diseases. Significant improvements in diagnosis, treatments, and mitigation of AD are likely to result from the development and application of a comprehensive approach to precision medicine (PM), as is the case with several other diseases. This strategy will probably be based on the achievements made in more sophisticated research areas, including cancer. PM will require the direct integration of neurology, neuroscience, and psychiatry into a paradigm of the healthcare field that turns away from the isolated method. PM is biomarker-guided treatment at a systems level that incorporates findings of the thorough pathophysiology of neurodegenerative disorders as well as methodological developments. Comprehensive examination and categorization of interrelated and convergent disease processes, an explanation of the genomic and epigenetic drivers, a description of the spatial and temporal paths of natural history, biological markers, and risk markers, as well as aspects about the regulation, and the ethical, governmental, and sociocultural repercussions of findings at a subclinical level all require clarification and realistic execution. Advances toward a comprehensive systems-based approach to PM may finally usher in a new era of scientific and technical achievement that will help to end the complications of AD.

24 April 2020 in Plants
Verified
Journal Article
Open access
PDF file
AWAdil Farooq Wali
Adil Farooq Wali
SRSummya Rashid
Summya Rashid
SRShahzada Rashid
Shahzada Rashid
MAMushtaq Ahmad Ansari
Mushtaq Ahmad Ansari
MKMohammad Rashid Khan
Mohammad Rashid Khan
MRMuneeb U Rehman
Muneeb U Rehman
Doxorubicin (Dox) is an operational and largely used anticancer drug, used to treat an array of malignancies. Nonetheless, its beneficial use is constrained due to its renal and hepatotoxicity dose dependently. Numerous research findings favor the use of antioxidants may impact Dox-induced liver injury/damage. In the current study, Wistar rats were given naringenin (50 and 100 mg/kg b.wt.) orally for 20 days as prophylactic dose, against the hepatotoxicity induced by single intraperitoneal injection of Dox (20 mg/kg b.wt.). Potency of naringenin against the liver damage caused by Dox was assessed by measuring malonyl aldehyde (MDA) as a by-product of lipid peroxidation, biochemical estimation of antioxidant enzyme system, reactive oxygen species (ROS) level, and inflammatory mediators. Naringenin-attenuated ROS production, ROS-induced lipid peroxidation, and replenished reduced antioxidant armory, namely, catalase (CAT), glutathione reductase (GR), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione (GSH). Naringenin similarly diminished expression of Cox-2 and levels of NF-κB and other inflammatory molecules induced by the Dox treatment. Histology added further evidence to the defensive effects of naringenin on Dox-induced liver damage. The outcomes of the current study reveal that oxidative stress and inflammation are meticulously linked with Dox-triggered damage, and naringenin illustrates the potential effect on Dox-induced hepatotoxicity probably through diminishing the oxidative stress and inflammation.

18 January 2018 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
MRMuneeb U Rehman
Muneeb U Rehman
MMManzoor Ur Rahman Mir
Manzoor Ur Rahman Mir
AFAdil Farooq
Adil Farooq
SRShahzada Rashid
Shahzada Rashid
BABilal Ahmad
Bilal Ahmad
MGMajid Ahmad Ganaie
Majid Ahmad Ganaie

14 March 2018 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
MRMuneeb U Rehman
Muneeb U Rehman
SRShahzada Rashid
Shahzada Rashid
SRSaiema Rasool
Saiema Rasool
SSSheeba Shakeel
Sheeba Shakeel
BABilal Ahmad
Bilal Ahmad
SBShowkat Ahmad Bhat
Showkat Ahmad Bhat
Development of diabetic nephropathy (DN) is directly linked to oxidative stress and inflammation. In this context, inflammatory and oxidative markers have gained much attention as targets for therapeutic intervention. We studied the effect of zingerone in a streptozotocin/high fat diet (STZ/HFD)-induced type 2 diabetic Wistar rat model. Zingerone also known as vanillyl acetone is a pharmacologically active compound present usually in dry ginger. STZ/HFD caused excessive increase in ROS and inflammation in experimental animals. The treatment with zingerone markedly abrogated ROS levels, inhibited the NF-кB activation and considerably reduced level of other downstream inflammatory molecules (TNF-α, IL-6, IL-1β), furthermore, zingerone treatment improved renal functioning by significantly decreasing the levels of kidney toxicity markers KIM-1, BUN, creatinine, and LDH and suppressed TGF-β. Collectively, these findings indicate that zingerone treatment improved renal function by anti-hyperglycaemic, anti-oxidant, and anti-inflammatory effects, suggesting the efficacy of zingerone in the treatment of DN.